Colon Cancer Clinical Trial
Official title:
Prospective Randomized Controlled Trial Comparing Water Exchange Colonoscopy and Air Colonoscopy in a Community Based Setting
The purpose of this study is to determine if screening colonoscopy performed on adults with the water exchange method, as opposed to the air method, will have a higher adenoma detection rate.
Screening colonoscopy with removal of pre-cancerous adenomas was recently shown to result in
a 53% reduction in mortality from colon cancer. While this clearly validates the practice of
screening colonoscopy, missed adenomas, especially in the proximal colon, defined as
including cecum, ascending colon, and transverse colon, remains a concern. This was
demonstrated in a study of 183 patients who underwent back-to-back colonoscopies. In this
population the overall miss rate for adenomas was 24% with proximal adenomas missed more
often (27%) than left colon adenomas (21%). Another study looked at 4192 patients in the
SEER (Surveillance, Epidemiology, and End Results) Medicare database who developed "interval
cancers", that is colon cancer in a patient who had a colonoscopy done in the previous 6-36
months. These interval cancers were predominantly in the proximal colon (Proximal 68%,
Distal 19.5%, rectum 10.4%, and unspecified 2.1%). This also suggests that pre-cancerous
lesions are being missed in the proximal colon. As such a method that can increase proximal
adenoma detection rate would be a welcome change.
One such emerging technique which shows promise for improving adenoma detection rate is
water colonoscopy. In one of the early studies employing the water method a trend towards a
higher ADR in the water method group was recognized (37% vs. 26%). The observation prompted
a retrospective analysis of 1178 cases of screening and surveillance colonoscopy performed
by a single endoscopist at the Sacramento VAMC, which showed an overall ADR (presence of at
least one adenoma) of 27% with air colonoscopy whereas that for the water method colonoscopy
was 35% (p=0.007). In a subsequent combined analysis of two prospective RCT of air vs. water
colonoscopy for screening and surveillance using scheduled unsedated colonoscopy [5] and
on-demand sedation [6], more patients were found to have at least one diminutive adenoma in
the proximal colon in the water method group than in the air group (28% vs. 14%,
respectively, p=0.0298). Another quasi randomized study of screening patients performed at
Phoenix VAMC using high definition equipment confirmed a significantly higher overall ADR
with the water method (n=177) compared with the air method (n=191) (57% vs. 46%) (p=0.03).
The odds of detecting an adenoma was 81% higher with the water method (OR 1.81; 95% CI:
1.12-2.90) and independent of age, body mass index (BMI), current smoking and alcohol use,
withdrawal time & quality of bowel preparation. In the proximal colon ADR was significantly
higher in patients examined with the water method than with air method (46% vs. 35%)
(p=0.03), particularly for adenomas <10 mm in size (38% vs. 25%) (p=007). These encouraging
preliminary data reflect the potential benefits of water method colonoscopy.
Our current research question is whether this benefit is seen in a community based
population as opposed to the VA population which is mostly male and Caucasian.
The investigators plan to perform a prospective, randomized controlled trial comparing
proximal adenoma detection rate between a water exchange colonoscopy group and an air
colonoscopy group. The investigators intend to employ scheduled sedation, instead of
on-demand sedation, to continue the current protocol in place at our institution.
Patients in both the study arms will undergo a split bowel preparation before colonoscopy.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Completed |
NCT03457454 -
Reducing Rural Colon Cancer Disparities
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04088955 -
A Digimed Oncology PharmacoTherapy Registry
|
||
Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
Terminated |
NCT01347645 -
Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT03390907 -
Hybrid APC Assisted EMR for Large Colon Polyps
|
N/A | |
Recruiting |
NCT03175224 -
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
|
Phase 2 | |
Completed |
NCT04079478 -
The AID Study: Artificial Intelligence for Colorectal Adenoma Detection
|
||
Active, not recruiting |
NCT04057274 -
Acute Effect of modeRate-intensity aerOBIc Exercise on Colon Cancer Cell Growth
|
N/A | |
Recruiting |
NCT03190941 -
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05147545 -
Impact of Exercise and Hyperlipidic Meal on Free Circulating DNA in Patients With Metastatic Colonic Cancer and Healthy Subjects
|
N/A | |
Recruiting |
NCT05026268 -
The Laparoscopic Right Colectomy With Intracoroporeal Anastomosis
|
N/A | |
Not yet recruiting |
NCT03277235 -
Effect of a Resilience Model-Based Care Plan in Newly Diagnosed Colorectal Cancer Patients
|
N/A | |
Active, not recruiting |
NCT02959541 -
PK/PD Investigation of Calciumfolinat in Blood, Tumor and Adjacent Mucosa in Patient With Colon Cancer
|
N/A | |
Active, not recruiting |
NCT02730702 -
Colon Cancer Risk-stratification Via Optical Analysis of Rectal Ultrastructure
|
||
Completed |
NCT02810652 -
Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection
|
N/A | |
Recruiting |
NCT02577627 -
Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC
|
N/A | |
Terminated |
NCT02628535 -
Safety Study of MGD009 in B7-H3-expressing Tumors
|
Phase 1 | |
Recruiting |
NCT02526836 -
Complete Mesocolic Excision With Central Vessel Ligation Compared With Conventional Surgery for Colon Cancer
|
Phase 2/Phase 3 |